Symphony Pharma Lifesciences Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is LACOSAMIDE, with a corresponding US DMF Number 26594.
Remarkably, this DMF maintains an Active status since its submission on December 17, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 20, 2013, and payment made on December 07, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II